200 related articles for article (PubMed ID: 20118908)
1. CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma.
Laharanne E; Chevret E; Idrissi Y; Gentil C; Longy M; Ferrer J; Dubus P; Jouary T; Vergier B; Beylot-Barry M; Merlio JP
Mod Pathol; 2010 Apr; 23(4):547-58. PubMed ID: 20118908
[TBL] [Abstract][Full Text] [Related]
2. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C
Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049
[TBL] [Abstract][Full Text] [Related]
3. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
[TBL] [Abstract][Full Text] [Related]
6. Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.
Genescà E; Lazarenkov A; Morgades M; Berbis G; Ruíz-Xivillé N; Gómez-Marzo P; Ribera J; Juncà J; González-Pérez A; Mercadal S; Guardia R; Artola MT; Moreno MJ; Martínez-López J; Zamora L; Barba P; Gil C; Tormo M; Cladera A; Novo A; Pratcorona M; Nomdedeu J; González-Campos J; Almeida M; Cervera J; Montesinos P; Batlle M; Vives S; Esteve J; Feliu E; Solé F; Orfao A; Ribera JM
J Hematol Oncol; 2018 Jul; 11(1):96. PubMed ID: 30041662
[TBL] [Abstract][Full Text] [Related]
7. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
[TBL] [Abstract][Full Text] [Related]
8. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
[TBL] [Abstract][Full Text] [Related]
9. Independent Loss of Methylthioadenosine Phosphorylase (MTAP) in Primary Cutaneous T-Cell Lymphoma.
Woollard WJ; Kalaivani NP; Jones CL; Roper C; Tung L; Lee JJ; Thomas BR; Tosi I; Ferreira S; Beyers CZ; McKenzie RCT; Butler RM; Lorenc A; Whittaker SJ; Mitchell TJ
J Invest Dermatol; 2016 Jun; 136(6):1238-1246. PubMed ID: 26872600
[TBL] [Abstract][Full Text] [Related]
10. Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma.
Dijkman R; Tensen CP; Jordanova ES; Knijnenburg J; Hoefnagel JJ; Mulder AA; Rosenberg C; Raap AK; Willemze R; Szuhai K; Vermeer MH
J Clin Oncol; 2006 Jan; 24(2):296-305. PubMed ID: 16330669
[TBL] [Abstract][Full Text] [Related]
11. CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours.
Rousseau E; Ruchoux MM; Scaravilli F; Chapon F; Vinchon M; De Smet C; Godfraind C; Vikkula M
Neuropathol Appl Neurobiol; 2003 Dec; 29(6):574-83. PubMed ID: 14636164
[TBL] [Abstract][Full Text] [Related]
12. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
13. Alterations of p14
López F; Sampedro T; Llorente JL; Hermsen M; Álvarez-Marcos C
Pathol Oncol Res; 2017 Jan; 23(1):63-71. PubMed ID: 27377733
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
Hutter G; Scheubner M; Zimmermann Y; Kalla J; Katzenberger T; Hübler K; Roth S; Hiddemann W; Ott G; Dreyling M
Genes Chromosomes Cancer; 2006 Feb; 45(2):203-10. PubMed ID: 16258956
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas.
Belaud-Rotureau MA; Marietta V; Vergier B; Mainhaguiet G; Turmo M; Idrissi Y; Ferrer J; Beylot-Barry M; Dubus P; Merlio JP
Virchows Arch; 2008 Jun; 452(6):607-20. PubMed ID: 18311490
[TBL] [Abstract][Full Text] [Related]
16. Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and sezary syndrome.
Scarisbrick JJ; Woolford AJ; Calonje E; Photiou A; Ferreira S; Orchard G; Russell-Jones R; Whittaker SJ
J Invest Dermatol; 2002 Mar; 118(3):493-9. PubMed ID: 11874489
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.
Weber RG; Hoischen A; Ehrler M; Zipper P; Kaulich K; Blaschke B; Becker AJ; Weber-Mangal S; Jauch A; Radlwimmer B; Schramm J; Wiestler OD; Lichter P; Reifenberger G
Oncogene; 2007 Feb; 26(7):1088-97. PubMed ID: 16909113
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas.
Kaune KM; Neumann C; Hallermann C; Haller F; Schön MP; Middel P
Exp Dermatol; 2011 Apr; 20(4):331-5. PubMed ID: 21410763
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic significance of CDKN2A/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30-positive lymphoproliferative disease.
Nicolae-Cristea AR; Benner MF; Zoutman WH; van Eijk R; Jansen PM; Tensen CP; Willemze R
Br J Dermatol; 2015 Mar; 172(3):784-8. PubMed ID: 25308604
[No Abstract] [Full Text] [Related]
20. Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes.
Wolter M; Reifenberger J; Blaschke B; Ichimura K; Schmidt EE; Collins VP; Reifenberger G
J Neuropathol Exp Neurol; 2001 Dec; 60(12):1170-80. PubMed ID: 11764089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
